Yan‐Qiong Cheng

679 total citations
17 papers, 240 citations indexed

About

Yan‐Qiong Cheng is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Neurology. According to data from OpenAlex, Yan‐Qiong Cheng has authored 17 papers receiving a total of 240 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Neurology. Recurrent topics in Yan‐Qiong Cheng's work include Neurological Disease Mechanisms and Treatments (2 papers), Neuroscience and Neuropharmacology Research (2 papers) and Sirtuins and Resveratrol in Medicine (2 papers). Yan‐Qiong Cheng is often cited by papers focused on Neurological Disease Mechanisms and Treatments (2 papers), Neuroscience and Neuropharmacology Research (2 papers) and Sirtuins and Resveratrol in Medicine (2 papers). Yan‐Qiong Cheng collaborates with scholars based in China, United States and Taiwan. Yan‐Qiong Cheng's co-authors include Aijun Liu, Qiuling Wu, Weidong Zhang, Ding‐Feng Su, Lili Lin, Qiwei Yang, Qian Jiao, Jianpeng Ma, Yongjie Chen and Mengting Li and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Yan‐Qiong Cheng

15 papers receiving 236 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan‐Qiong Cheng China 9 97 31 30 25 24 17 240
Lin‐Sheng Yu China 11 156 1.6× 29 0.9× 15 0.5× 35 1.4× 21 0.9× 22 354
Yuanfang Guo China 12 214 2.2× 41 1.3× 30 1.0× 15 0.6× 40 1.7× 22 412
Xiao Ni China 10 219 2.3× 36 1.2× 21 0.7× 19 0.8× 52 2.2× 24 465
Youli Cai China 6 149 1.5× 16 0.5× 39 1.3× 18 0.7× 33 1.4× 6 318
Jiuan‐Miaw Liao Taiwan 11 170 1.8× 33 1.1× 30 1.0× 24 1.0× 27 1.1× 24 368
Koulong Zheng China 11 176 1.8× 16 0.5× 20 0.7× 15 0.6× 34 1.4× 19 269
Yanju Gong China 9 115 1.2× 23 0.7× 26 0.9× 23 0.9× 28 1.2× 31 295
Lili Chi China 12 185 1.9× 30 1.0× 45 1.5× 19 0.8× 48 2.0× 29 447
Yinliang Qi China 11 140 1.4× 17 0.5× 40 1.3× 30 1.2× 61 2.5× 36 351

Countries citing papers authored by Yan‐Qiong Cheng

Since Specialization
Citations

This map shows the geographic impact of Yan‐Qiong Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan‐Qiong Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan‐Qiong Cheng more than expected).

Fields of papers citing papers by Yan‐Qiong Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan‐Qiong Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan‐Qiong Cheng. The network helps show where Yan‐Qiong Cheng may publish in the future.

Co-authorship network of co-authors of Yan‐Qiong Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yan‐Qiong Cheng. A scholar is included among the top collaborators of Yan‐Qiong Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan‐Qiong Cheng. Yan‐Qiong Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Cheng, Yan‐Qiong, et al.. (2024). The Dopamine Transporter Is a New Target for Ischemic Stroke. CNS Neuroscience & Therapeutics. 30(10). e70092–e70092.
3.
Chen, Yong, et al.. (2023). A High-Performance Redox Electrochemical Capacitor: Confinement of Sodium Anthraquinone-2-Sulfonate in Porous Carbons with Electric-Field Assistance. ACS Applied Energy Materials. 6(12). 6532–6542. 10 indexed citations
4.
Cheng, Yan‐Qiong, et al.. (2023). Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo. Pharmacology Research & Perspectives. 11(2). e01064–e01064. 6 indexed citations
5.
Li, Mengting, Yan‐Qiong Cheng, Lei Zhang, et al.. (2021). The Synergistic Effect of Ginkgo biloba Extract 50 and Aspirin Against Platelet Aggregation. Drug Design Development and Therapy. Volume 15. 3543–3560. 31 indexed citations
6.
Wu, Qiuling, Yan‐Qiong Cheng, Aijun Liu, & Weidong Zhang. (2020). Formononetin recovered injured nerve functions by enhancing synaptic plasticity in ischemic stroke rats. Biochemical and Biophysical Research Communications. 525(1). 67–72. 30 indexed citations
7.
Yang, Qiwei, Weiwei Chu, Wei Yang, et al.. (2020). Identification of RNA Transcript Makers Associated With Prognosis of Kidney Renal Clear Cell Carcinoma by a Competing Endogenous RNA Network Analysis. Frontiers in Genetics. 11. 540094–540094. 18 indexed citations
8.
Cheng, Yan‐Qiong, et al.. (2019). The Sirt1 activator resveratrol improved hematopoiesis in pancytopenia mice induced by irradiation. Journal of Pharmacological Sciences. 140(1). 79–85. 8 indexed citations
9.
Wang, Kaijian, Chao Wang, Lihe Dai, et al.. (2018). Targeting an Autocrine Regulatory Loop in Cancer Stem-like Cells Impairs the Progression and Chemotherapy Resistance of Bladder Cancer. Clinical Cancer Research. 25(3). 1070–1086. 38 indexed citations
10.
Zhang, Ying, Yan‐Qiong Cheng, Weizhong Wang, et al.. (2018). Metabolic syndrome emerges after artificial selection for low baroreflex sensitivity. CNS Neuroscience & Therapeutics. 24(9). 828–836. 5 indexed citations
11.
Wang, Ye, Qiwei Yang, Qing Yang, et al.. (2017). Cuprous oxide nanoparticles inhibit prostate cancer by attenuating the stemness of cancer cells via inhibition of the Wnt signaling pathway. International Journal of Nanomedicine. Volume 12. 2569–2579. 34 indexed citations
12.
Cheng, Yan‐Qiong, et al.. (2017). Synergism of amlodipine and candesartan on blood pressure reduction and organ protection in hypertensive rats. Clinical and Experimental Pharmacology and Physiology. 45(6). 514–524. 3 indexed citations
13.
Jiao, Qian, Jingming Zhang, Lili Lin, et al.. (2015). A Combination of Neostigmine and Anisodamine Protects against Ischemic Stroke by Activating α7nAChR. International Journal of Stroke. 10(5). 737–744. 14 indexed citations
14.
15.
Wang, Wei, Lili Lin, Jin‐Min Guo, et al.. (2015). Heavy Ethanol Consumption Aggravates the Ischemic Cerebral Injury by Inhibiting ALDH2. International Journal of Stroke. 10(8). 1261–1269. 17 indexed citations
16.
Qi, Haiyan, et al.. (2014). The Antiaging Activity and Cerebral Protection of Rapamycin at Micro‐doses. CNS Neuroscience & Therapeutics. 20(11). 991–998. 16 indexed citations
17.
Fan, Shou‐Zen, et al.. (1994). Heart rate variability--a useful non-invasive tool in anesthesia.. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026